Report topline data from the placebo-controlled SAD and MAD Phase 1 trials of CTI-1601
Delivered by the deadline
AI-assessed · human review in progress Found and assessed by AI from the cited sources. Shown with its evidence; it is not counted in any Kept Score until confirmed.
- Announced
- 4 Mar 2021
- Due
- 30 Jun 2021
- Delivered
- May 2021
- Deadline
- Met
- Late
- Not met
- Today
What the company said
“expect to report topline data from both this study and our placebo-controlled single- ascending dose (SAD) study in the second quarter”
What we found
Evidence strength A What the grades mean
Later 10-Q filings state that Larimar reported positive topline Phase 1 FA data in May 2021, before the end-of-Q2 deadline, after completing SAD and MAD dosing.
-
A Larimar Therapeutics, Inc. 10-Q filed 2021-08-12
“In May 2021, Larimar reported positive topline data from its Phase 1 Friedreich’s ataxia (FA) program after completing dosing of the single ascending dose (SAD) trial in December 2020 and of the multiple ascending dose (MAD) trial in March 2021.” ✓ confirmed on the page
-
A Larimar Therapeutics, Inc. 10-Q filed 2021-08-12
“In May 2021, we reported positive topline data from our Phase 1 Friedreich’s ataxia (FA) program after completing dosing of the single ascending dose (SAD) trial in December 2020 and of the multiple ascending dose (MAD) trial in March 2021.” ✓ confirmed on the page
Checked 27 Oct 2026.
Commitment DNA
The structured record of this commitment. Fields the company did not state are left blank rather than guessed.
- Event type
- Clinical readout
- Indicative materiality
- Medium rules
- Action
- Report
- Deliverable
- Topline data from SAD and MAD Phase 1 trials of CTI-1601
- Language
- Expected (“expects”, “plans”)
- In the company’s control
- Medium
- Specificity
- High
How this entry was checked
- Commitment recordedThe company's words were matched word for word against the filing.
- First checkAn AI model, Claude (Anthropic), read the company's later filings and recorded the outcome with a quoted passage.
Not yet confirmed. Shown on the record, but it will not count in any score until it is confirmed. How verification works
Are you Larimar Therapeutics, Inc.? You can publish an official statement next to this entry, free. Add a statement.
Is something here wrong or out of date? Companies and readers can ask us to check it. Please bring a link to a public source.
Report an error in this entry Reference: KI-C-2021-LRMR-025147 · Corrections policy